The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
Open accessAbstract
In mammalian cells, two cellular organelles, mitochondria and peroxisomes, share the ability to degrade fatty acid chains. Although each organelle harbors its own fatty acid β-oxidation pathway, a distinct mitochondrial system feeds the oxidative phosphorylation pathway for ATP synthesis. At the same time, the peroxisomal β-oxidation pathway participates in cellular thermogenesis. A scientific milestone in 1965 helped discover the hepatomegaly effect in rat liver by clofibrate, subsequently identified as a peroxisome proliferator in rodents and an activator of the peroxisomal fatty acid β-oxidation pathway. These peroxisome proliferators were later identified as activating ligands of Peroxisome Proliferator-Activated Receptor α (PPARα), cloned in 1990. The ligand-activated heterodimer PPARα/RXRα recognizes a DNA sequence, called PPRE (Peroxisome Proliferator Response Element), corresponding to two half-consensus hexanucleotide motifs, AGGTCA, separated by one nucleotide. Accordingly, the assembled complex containing PPRE/PPARα/RXRα/ligands/Coregulators controls the expression of the genes involved in liver peroxisomal fatty acid β-oxidation. This review mobilizes a considerable number of findings that discuss miscellaneous axes, covering the detailed expression pattern of PPARα in species and tissues, the lessons from several PPARα KO mouse models and the modulation of PPARα function by dietary micronutrients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Coactivator condensation at super-enhancers links phase separation and gene control
Sabari, B. R., Dall’Agnese, A., Boija, A., Klein, I. A., Coffey, E. L., Shrinivas, K., Abraham, B. J., Hannett, N. M., Zamudio, A. V., Manteiga, J. C., et al. (2018) · Science · doi:10.1126/science.aar3958 · Cited by 2,595
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,048
JASPAR 2020: update of the open-access database of transcription factor binding profiles
Fornes, O., Castro-Mondragon, J. A., Khan, A., van der Lee, R., Zhang, X., Richmond, P. A., Modi, B. P., Correard, S., Gheorghe, M., Baranašić, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1001 · Cited by 1,763
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Scarpulla, R. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.019 · Cited by 1,281
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Lazarow, P. B., & De Duve, C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.6.2043 · Cited by 1,137
Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., & Li, X. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.006 · Cited by 1,003
Self-citationVarga, T., Czimmerer, Z., & Nagy, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.014 · Cited by 933
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Reddy, J. K., Lalvvai, N. D., & Farber, E. (1983) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448309029317 · Cited by 879
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
PPARs at the crossroads of lipid signaling and inflammation
Wahli, W., & Michalik, L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.001 · Cited by 675
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Transcription regulation by the Mediator complex
Soutourina, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.115 · Cited by 605
NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
HESS, R., STÄUBLI, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 594
Martin, G., Schoonjans, K., Lefebvre, A.-M., Staels, B., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28210 · Cited by 551
Mirza, A. Z., Althagafi, I. I., & Shamshad, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.067 · Cited by 544
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062061 · Cited by 540
Xu, H. E., Lambert, M. H., Montana, V. G., Plunket, K. D., Moore, L. B., Collins, J. L., Oplinger, J. A., Kliewer, S. A., Gampe, R. T., McKee, D. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241410198 · Cited by 538
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Chakravarthy, M. V., Lodhi, I. J., Yin, L., Malapaka, R. R. V., Xu, H. E., Turk, J., & Semenkovich, C. F. (2009) · Cell · doi:10.1016/j.cell.2009.05.036 · Cited by 533
Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., & Latruffe, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16710 · Cited by 524
Self-citationSher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice
Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., & Leclercq, I. (2003) · Hepatology · doi:10.1053/jhep.2003.50307 · Cited by 476
Medical significance of peroxisome proliferator-activated receptors
Vamecq, J., & Latruffe, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10364-1 · Cited by 468
Self-citationDietary Intake Regulates the Circulating Inflammatory Monocyte Pool
Jordan, S., Tung, N., Casanova-Acebes, M., Chang, C., Cantoni, C., Zhang, D., Wirtz, T. H., Naik, S., Rose, S. A., Brocker, C. N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.050 · Cited by 437
Reddy, J. K., & Mannaerts, G. P. (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.002015 · Cited by 417
A Transcriptional Switch Mediated by Cofactor Methylation
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., & Evans, R. M. (2001) · Science · doi:10.1126/science.1065961 · Cited by 416
Costet, P., Legendre, C., Moré, J., Edgar, A., Galtier, P., & Pineau, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29577 · Cited by 402
The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
Kersten, S., & Stienstra, R. (2017) · Biochimie · doi:10.1016/j.biochi.2016.12.019 · Cited by 394
The retinoid X receptors and their ligands
Dawson, M. I., & Xia, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.014 · Cited by 387
Peroxisome proliferator-activated receptors and inflammation
Moraes, L. A., Piqueras, L., & Bishop-Bailey, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.007 · Cited by 376
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 374
Wanders, R. J. A., Waterham, H. R., & Ferdinandusse, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00083 · Cited by 366
Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefebvre, P., Taskinen, M.-R., Van Hul, W., Mertens, I., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.019 · Cited by 357
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Brown, J. D., & Plutzky, J. (2007) · Circulation · doi:10.1161/circulationaha.104.475673 · Cited by 340
Patsouris, D., Reddy, J. K., Müller, M., & Kersten, S. (2006) · Endocrinology · doi:10.1210/en.2005-1132 · Cited by 340
Wójtowicz, S., Strosznajder, A. K., Jeżyna, M., & Strosznajder, J. B. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02993-5 · Cited by 327
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316
Retinoid X receptors: common heterodimerization partners with distinct functions
Lefebvre, P., Benomar, Y., & Staels, B. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.009 · Cited by 309
Gonzalez, F. J., Peters, J. M., & Cattley, R. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.22.1702 · Cited by 290
Nuclear receptors and nonalcoholic fatty liver disease
Cave, M. C., Clair, H. B., Hardesty, J. E., Falkner, K. C., Feng, W., Clark, B. J., Sidey, J., Shi, H., Aqel, B. A., McClain, C. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.002 · Cited by 279
Wagner, N., & Wagner, K.-D. (2020) · Cells · doi:10.3390/cells9112367 · Cited by 271
Bardot, O., Aldridge, T. C., Latruffe, N., & Green, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1378 · Cited by 269
Self-citationLigand Selectivity of the Peroxisome Proliferator-Activated Receptor α
Lin, Q., Ruuska, S. E., Shaw, N. S., Dong, D., & Noy, N. (1999) · Biochemistry · doi:10.1021/bi9816094 · Cited by 263
Girnun, G. D., Domann, F. E., Moore, S. A., & Robbins, M. E. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0020 · Cited by 259
PPARs and ERRs: molecular mediators of mitochondrial metabolism
Fan, W., & Evans, R. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.11.002 · Cited by 250
Ghisletti, S., Huang, W., Jepsen, K., Benner, C., Hardiman, G., Rosenfeld, M. G., & Glass, C. K. (2009) · Genes & Development · doi:10.1101/gad.1773109 · Cited by 248
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Tenenbaum, A., Motro, M., & Fisman, E. Z. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-14 · Cited by 246
Localization of PPAR isotypes in the adult mouse and human brain
Warden, A., Truitt, J., Merriman, M., Ponomareva, O., Jameson, K., Ferguson, L. B., Mayfield, R. D., & Harris, R. A. (2016) · Scientific Reports · doi:10.1038/srep27618 · Cited by 242
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
Hong, F., Pan, S., Guo, Y., Xu, P., & Zhai, Y. (2019) · Molecules · doi:10.3390/molecules24142545 · Cited by 233
INDIVIDUAL PEROXISOMAL βT‐OXIDATION ENZYMES*
Hashimoto, T. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb21403.x · Cited by 231
Song, C., Hotz-Wagenblatt, A., Voit, R., & Grummt, I. (2017) · Genes & Development · doi:10.1101/gad.300624.117 · Cited by 226
SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescence
Han, L., Zhou, R., Niu, J., McNutt, M. A., Wang, P., & Tong, T. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq609 · Cited by 219
Functional Regulation of PPARs through Post-Translational Modifications
Brunmeir, R., & Xu, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061738 · Cited by 219
Integrative regulation of physiology by histone deacetylase 3
Emmett, M. J., & Lazar, M. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0076-0 · Cited by 202
Oxidized phospholipids activate PPARα in a phospholipase A2‐dependent manner
Delerive, P., Furman, C., Teissier, E., Fruchart, J.-C., Duriez, P., & Staels, B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01364-8 · Cited by 199
Pawar, A., & Jump, D. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306238200 · Cited by 196
The Mediator Complex: At the Nexus of RNA Polymerase II Transcription
Jeronimo, C., & Robert, F. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.001 · Cited by 195
Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation
Stienstra, R., Mandard, S., Patsouris, D., Maass, C., Kersten, S., & Müller, M. (2007) · Endocrinology · doi:10.1210/en.2007-0014 · Cited by 191
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin
Shalev, A. (1996) · Endocrinology · doi:10.1210/en.137.10.4499 · Cited by 187
PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity
Corrales, P., Vidal-Puig, A., & Medina-Gómez, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072124 · Cited by 185
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α
Han, L., Shen, W.-J., Bittner, S., Kraemer, F. B., & Azhar, S. (2017) · Future Cardiology · doi:10.2217/fca-2016-0059 · Cited by 183
Deactivating Fatty Acids: Acyl-CoA Thioesterase-Mediated Control of Lipid Metabolism
Tillander, V., Alexson, S. E. H., & Cohen, D. E. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.03.001 · Cited by 182
Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
Preiss, D., Tikkanen, M. J., Welsh, P., Ford, I., Lovato, L. C., Elam, M. B., LaRosa, J. C., DeMicco, D. A., Colhoun, H. M., Goldenberg, I., et al. (2012) · JAMA · doi:10.1001/jama.2012.8439 · Cited by 181 · cited 1×
“[116] proved that the chronic administration of peroxisome proliferators to rodents causes hepatocellular carcinoma, and it may also increase the risk of gallstones and cause anemia and leukopenia [117].”
BackgroundThe Nuclear Receptor Superfamily and Drug Discovery
Moore, J. T., Collins, J. L., & Pearce, K. H. (2006) · ChemMedChem · doi:10.1002/cmdc.200600006 · Cited by 177
Zhang, C., Deng, J., Liu, D., Tuo, X., Xiao, L., Lai, B., Yao, Q., Liu, J., Yang, H., & Wang, N. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14482 · Cited by 177
PPAR: a mediator of peroxisome proliferator action
Green, S. (1995) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(95)00136-0 · Cited by 176
Marcus, S. L., Miyata, K. S., Zhang, B., Subramani, S., Rachubinski, R. A., & Capone, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5723 · Cited by 171
Seedorf, U., Brysch, P., Engel, T., Schrage, K., & Assmann, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31960-9 · Cited by 170
Ellinghaus, P., Wolfrum, C., Assmann, G., Spener, F., & Seedorf, U. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2766 · Cited by 170
Lamichane, S., Lamichane, B. D., & Kwon, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040949 · Cited by 170
Zomer, A. W. M., van der Burg, B., Jansen, G. A., Wanders, R. J. A., Poll‐The, B. T., & van der Saag, P. T. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31973-8 · Cited by 169
Hostetler, H. A., Petrescu, A. D., Kier, A. B., & Schroeder, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412062200 · Cited by 169
Peroxisomes, lipid metabolism and lipotoxicity
Wanders, R. J. A., Ferdinandusse, S., Brites, P., & Kemp, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.001 · Cited by 169
General Molecular Biology and Architecture of Nuclear Receptors
Pawlak, M., Lefebvre, P., & Staels, B. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436641 · Cited by 167
Roy, A., Jana, M., Corbett, G. T., Ramaswamy, S., Kordower, J. H., Gonzalez, F. J., & Pahan, K. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.028 · Cited by 167
Osumi, T., Ishii, N., Hijikata, M., Kamijo, K., Ozasa, H., Furuta, S., Miyazawa, S., Kondo, K., Inoue, K., & Kagamiyama, H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39435-8 · Cited by 164
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Inokuchi-Shimizu, S., Park, E. J., Roh, Y. S., Yang, L., Zhang, B., Song, J., Liang, S., Pimienta, M., Taniguchi, K., Wu, X., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74068 · Cited by 164
Koch, J., Pranjic, K., Huber, A., Ellinger, A., Hartig, A., Kragler, F., & Brocard, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.064907 · Cited by 163
The potential of natural products for targeting PPARα
Rigano, D., Sirignano, C., & Taglialatela‐Scafati, O. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.05.005 · Cited by 160
Peroxisome proliferator-activated receptors, Metabolic Syndrome and Cardiovascular Disease
Azhar, S. (2010) · Future Cardiology · doi:10.2217/fca.10.86 · Cited by 159
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
Régnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouché, E., Lasserre, F., Naylies, C., Bétoulières, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63579-3 · Cited by 159
Peroxisome proliferator-activated receptors: finding the orphan a home
Green, S., & Wahli, W. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90294-1 · Cited by 158
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
Takada, I., & Makishima, M. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1703952 · Cited by 155
Peroxisomal acyl-CoA synthetases
Watkins, P. A., & Ellis, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.010 · Cited by 152
Surapureddi, S., Yu, S., Bu, H., Hashimoto, T., Yeldandi, A. V., Kashireddy, P. V., Cherkaoui‐Malki, M., Qi, C., Zhu, Y.-J., Rao, M. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182426699 · Cited by 147
Self-citationValenzuela, R., Illesca, P., Echeverría, F., Espinosa, A., Rincón‐Cervera, M. Á., Ortíz, M., Hernández‐Rodas, M. C., Valenzuela, A., & Videla, L. A. (2017) · Food & Function · doi:10.1039/c7fo00090a · Cited by 141
Feige, J. N., Gelman, L., Tudor, C., Engelborghs, Y., Wahli, W., & Desvergne, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500786200 · Cited by 137
Lalwani, N. D., Reddy, M. K., Qureshi, S. A., et al. (1983) · Human Toxicology · doi:10.1177/096032718300200103 · Cited by 136
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation
Campolongo, P., Roozendaal, B., Trezza, V., Cuomo, V., Astarita, G., Fu, J., McGaugh, J. L., & Piomelli, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903038106 · Cited by 133
Pirozzi, C., Lama, A., Simeoli, R., Paciello, O., Pagano, T. B., Mollica, M. P., Guida, F., Russo, R., Magliocca, S., Canani, R. B., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.004 · Cited by 127
Narala, V. R., Adapala, R. K., Suresh, M. V., Brock, T. G., Peters-Golden, M., & Reddy, R. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085118 · Cited by 126
DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense
Taschuk, F., & Cherry, S. R. (2020) · Viruses · doi:10.3390/v12020181 · Cited by 125
Dixon, E. D., Nardo, A. D., Claudel, T., & Trauner, M. (2021) · Genes · doi:10.3390/genes12050645 · Cited by 125
Oleic acid-derived oleoylethanolamide: A nutritional science perspective
Bowen, K. J., Kris‐Etherton, P. M., Shearer, G. C., West, S. G., Reddivari, L., & Jones, P. J. H. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.04.001 · Cited by 122
Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
Park, H. S., Lim, J. H., Kim, M. Y., Kim, Y., Hong, Y. A., Choi, S. R., Chung, S., Kim, H. W., Choi, B. S., Kim, Y., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0922-9 · Cited by 119
Bernardes, A., Souza, P. C. T., Muniz, J. R. C., Ricci, C. G., Ayers, S. D., Parekh, N., Godoy, A. S., Trivella, D. B. B., Reinach, P. S., Webb, P., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.05.010 · Cited by 118
Green tea and tea polyphenols in cancer prevention
Chen, D., Daniel, K. G., Kuhn, D. J., Kazi, A., Bhuiyan, M. N., Li, L., Wang, Z., Wan, S. B., Lam, W. H., Chan, T. H., et al. (2004) · Frontiers in bioscience · doi:10.2741/1421 · Cited by 118
Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity
Stec, D. E., Gordon, D. M., Hipp, J., Hong, S., Mitchell, Z. L., Franco, N. R., Robison, J., Anderson, C. D., Stec, D. F., & Hinds, T. D. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2019 · Cited by 116
Yeast Two‐Hybrid Assay to Identify Interacting Proteins
Paiano, A., Margiotta, A., Luca, M. D., & Bucci, C. (2018) · Current Protocols in Protein Science · doi:10.1002/cpps.70 · Cited by 115
Hostetler, H. A., Kier, A. B., & Schroeder, F. (2006) · Biochemistry · doi:10.1021/bi060198l · Cited by 112
SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα
Naiman, S., Huynh, F. K., Gil, R., Glick, Y., Shahar, Y., Touitou, N., Nahum, L., Avivi, M. Y., Roichman, A., Kanfi, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.067 · Cited by 112
PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors
Luo, C., Widlund, H. R., & Puigserver, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.006 · Cited by 111
PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates
Kamata, S., Oyama, T., Saito, K., Honda, A., Yamamoto, Y., Suda, K., Ishikawa, R., Itoh, T., Watanabe, Y., Shibata, T., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101727 · Cited by 111
Iershov, A., Nemazanyy, I., Alkhoury, C., Girard, M., Barth, E., Cagnard, N., Montagner, A., Chretien, D., Rugarli, E. I., Guillou, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09598-9 · Cited by 109
Peroxisome Proliferators and Peroxisome Proliferator-Activated Receptor α
Reddy, J. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63787-x · Cited by 105
Kaimoto, S., Hoshino, A., Ariyoshi, M., Okawa, Y., Tateishi, S., Ono, K., Uchihashi, M., Fukai, K., Iwai-Kanai, E., & Matoba, S. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2016 · Cited by 103
Woodyatt, N. J., Lambe, K. G., Myers, K. A., Tugwood, J. D., & Roberts, R. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.369 · Cited by 101
Cooperative regulation in development by SMRT and FOXP1Preprint
Jepsen, K., Gleiberman, A. S., Shi, C., Simon, D. I., & Rosenfeld, M. G. (2008) · Genes & Development · doi:10.1101/gad.1637108 · Cited by 100
Goto, T., Takahashi, N., Kato, S., Egawa, K., Ebisu, S., Moriyama, T., Fushiki, T., & Kawada, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.077 · Cited by 99
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
Mariani, M. M., Malm, T., Lamb, R., Jay, T. R., Neilson, L., Casali, B., Medarametla, L., & Landreth, G. E. (2017) · Scientific Reports · doi:10.1038/srep42270 · Cited by 98
Gha Young, L. E. E., Kim, N. H., Zhao, Z., Soo, B., & Kim, Y. S. (2004) · Biochemical Journal · doi:10.1042/bj20031565 · Cited by 97
Gao, Q., Jia, Y., Yang, G., Zhang, X., Boddu, P. C., Petersen, B. E., Narsingam, S., Zhu, Y.-J., Thimmapaya, B., Kanwar, Y. S., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.018 · Cited by 95
Floyd, Z. E., & Stephens, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.014 · Cited by 95
Wadosky, K. M., & Willis, M. S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00703.2011 · Cited by 93
Brocker, C. N., Yue, J., Kim, D., Qu, A., Bonzo, J. A., & Gonzalez, F. J. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2016 · Cited by 93
Chen, X., Wang, Q., Shao, M., Ma, L., Guo, D., Wu, Y. L., Gao, P., Wang, X., Li, W., Li, C., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109487 · Cited by 93
Functional significance of the two ACOX1 isoforms and their crosstalks with PPARα and RXRα
Vluggens, A., Andreoletti, P., Viswakarma, N., Jia, Y., Matsumoto, K., Kulik, W., Khan, M., Huang, J., Guo, D., Yu, S., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.46 · Cited by 91
Self-citationBrocker, C. N., Patel, D. P., Velenosi, T. J., Kim, D., Yan, T., Yue, J., Li, G., Krausz, K. W., & Gonzalez, F. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088419 · Cited by 90
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria.
Tonsgard, J. H., & Getz, G. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112039 · Cited by 88
Qi, W., Gutierrez, G. E., Gao, X., Dixon, H., McDonough, J. A., Marini, A. M., & Fisher, A. L. (2017) · Aging Cell · doi:10.1111/acel.12651 · Cited by 88
Identification and characterization of PPARα ligands in the hippocampus
Roy, A., Kundu, M., Jana, M., Mishra, R. K., Yung, Y. P., Luan, C.-H., Gonzalez, F. J., & Pahan, K. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2204 · Cited by 86
Haro, D., Marrero, P. F., & Relat, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061386 · Cited by 81
Latruffe, N., Cherkaoui‐Malki, M., Nicolas-Francès, V., Clémencet, M.-C., Jannin, B., & Berlot, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00416-0 · Cited by 80
Self-citationZhang, B., Marcus, S. L., Miyata, K., Subramani, S. E., Capone, J. P., & Rachubinski, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31476-5 · Cited by 79
Kosgei, V. J., Coelho, D., Guéant‐Rodriguez, R., & Guéant, J. (2020) · Cells · doi:10.3390/cells9081882 · Cited by 79
The metabolic coregulator RIP140: an update
Fritah, A., Christian, M., & Parker, M. G. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2010 · Cited by 77
Dual PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction
Kalliora, C., Kyriazis, I. D., Oka, S., Lieu, M., Yue, Y., Área-Gómez, E., Pol, C. J., Tian, Y., Mizushima, W., Chin, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129556 · Cited by 77
Rana, R., Surapureddi, S., Kam, W., Ferguson, S., & Goldstein, J. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00847-10 · Cited by 76
Self-citationCardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 76
Insights into the role of hepatocyte PPARα activity in response to fasting
Régnier, M., Polizzi, A., Lippi, Y., Fouché, E., Michel, G., Lukowicz, C., Smati, S., Marrot, A., Lasserre, F., Naylies, C., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.035 · Cited by 76
Macrophage-derived lipid agonists of PPAR-αas intrinsic controllers of inflammation
Pontis, S., Ribeiro, A., Sasso, O., & Piomelli, D. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1092944 · Cited by 75
Kandel, B. A., Thomas, M., Winter, S., Damm, G., Seehofer, D., Burk, O., Schwab, M. G., & Zanger, U. M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.007 · Cited by 75
Polyphenols of the Mediterranean Diet and Their Metabolites in the Prevention of Colorectal Cancer
Yammine, A., Namsi, A., Fasseur, D., Mackrill, J. J., Lizard, G., & Latruffe, N. (2021) · Molecules · doi:10.3390/molecules26123483 · Cited by 75
Self-citationHepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation
Cherkaoui‐Malki, M., Surapureddi, S., Hajj, H. I. E., Vamecq, J., & Andreoletti, P. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762765 · Cited by 74
Self-citationVitaglione, P., Mazzone, G., Lembo, V., D’Argenio, G., Rossi, A., Guido, M., Savoia, M., Salomone, F., Mennella, I., Filippis, F. D., et al. (2019) · Journal of Nutritional Science · doi:10.1017/jns.2019.10 · Cited by 74
Chen, J.-W., Kong, Z., Tsai, M., Lo, C., Ho, C., & Lai, C. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.005 · Cited by 73
Oyama, T., Toyota, K., Waku, T., Hirakawa, Y., Nagasawa, N., Kasuga, J.-I., Hashimoto, Y., Miyachi, H., & Morikawa, K. (2009) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909015935 · Cited by 71
Misra, P., & Reddy, J. K. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.011 · Cited by 71
Stallcup, M. R., & Poulard, C. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.02.006 · Cited by 68
Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity‐an updated review
Payahoo, L., Khajebishak, Y., & Ostadrahimi, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27913 · Cited by 67
Hepatic dysfunction in peroxisomal disorders
Baes, M. I., & Veldhoven, P. P. V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.035 · Cited by 66
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells
Rogue, A., Anthérieu, S., Vluggens, A., Umbdenstock, T., Claude, N., de la Moureyre-Spire, C., Weaver, R. J., & Guillouzo, A. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.02.001 · Cited by 65
Shimizu, M., Yamashita, D., Yamaguchi, T., Hirose, F., & Osumi, T. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9052-z · Cited by 64
Oleoylethanolamide: A fat ally in the fight against obesity
Brown, J. D., Azari, E. K., & Ayala, J. E. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.02.034 · Cited by 61
Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA
de Vera, I. M. S., Zheng, J., Novick, S. J., Shang, J., Hughes, T., Brust, R., Munoz‐Tello, P., Gardner, W. J., Marciano, D. P., Kong, X., et al. (2017) · Structure · doi:10.1016/j.str.2017.07.019 · Cited by 61
Hepatic Lipid Catabolism via PPARα-Lysosomal Crosstalk
Sinha, R. A., Rajak, S., Singh, B. K., & Yen, P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072391 · Cited by 60
More, V. R., Campos, C. R., Evans, R. A., Oliver, K. D., Chan, G. N., Miller, D. S., & Cannon, R. E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16650216 · Cited by 59
Sun, X., Yamasaki, M., Katsube, T., & Shiwaku, K. (2015) · Nutrition Research and Practice · doi:10.4162/nrp.2015.9.2.137 · Cited by 59
Brady, P. S., Marine, K. A., Brady, L. J., & Ramsay, R. R. (1989) · Biochemical Journal · doi:10.1042/bj2600093 · Cited by 59
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Tufano, M., & Pinna, G. (2020) · Molecules · doi:10.3390/molecules25051062 · Cited by 58
Raso, G. M., Esposito, E., Vitiello, S., Iacono, A., Santoro, A. N., D’Agostino, G., Sasso, O., Russo, R., Piazza, P. V., Calignano, A., et al. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02152.x · Cited by 57
Kumar, S., Cunningham, T. J., & Duester, G. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.08.005 · Cited by 57
Venkata, N. G., Robinson, J. A., Cabot, P. J., Davis, B. J., Monteith, G. R., & Roberts‐Thomson, S. J. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.11.001 · Cited by 56
Chen, X., Shang, L., Deng, S., Li, P., Chen, K., Gao, T., Zhang, X., Chen, Z., & Zeng, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013583 · Cited by 56
Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism
Rando, G., Tan, C. K., Khaled, N., Montagner, A., Leuenberger, N., Bertrand‐Michel, J., Paramalingam, E., Guillou, H., & Wahli, W. (2016) · eLife · doi:10.7554/elife.11853 · Cited by 55
Raas, Q., Gondcaille, C., Hamon, Y., Leoni, V., Caccia, C., Ménétrier, F., Lizard, G., Trompier, D., & Savary, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.02.006 · Cited by 53
Paola, R. D., Cordaro, M., Crupi, R., Siracusa, R., Campolo, M., Bruschetta, G., Fusco, R., Pugliatti, P., Esposito, E., & Cuzzocrea, S. (2016) · Shock · doi:10.1097/shk.0000000000000578 · Cited by 53
Ranea‐Robles, P., Violante, S. N., Argmann, C., Dodatko, T., Bhattacharya, D., Chen, H., Yu, C., Friedman, S. L., Puchowicz, M. A., & Houten, S. M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03869-9 · Cited by 53
Bervejillo, M. L., & Ferreira, A. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_3 · Cited by 52
Castrejón-Téllez, V., Rodrı́guez-Pérez, J. M., Pérez-Torres, I., Pérez‐Hernández, N., Cruz‐Lagunas, A., Guarner‐Lans, V., Vargas‐Alarcón, G., & Rubio-Ruiz, M. E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071069 · Cited by 51
Elholm, M., Dam, I., Jørgensen, C., Krogsdam, A., Holst, D., Kratchmarova, I., Göttlicher, M., Gustafsson, J.-Α., Berge, R. K., Flatmark, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101073200 · Cited by 50
Ning, L.-J., He, A., Lu, D., Li, J., Qiao, F., Li, D., Zhang, M., Chen, L., & Du, Z. (2017) · Scientific Reports · doi:10.1038/srep41706 · Cited by 50
Dumesic, P. A., Egan, D. F., Gut, P., Tran, M. T., Parisi, A., Chatterjee, N., Jedrychowski, M. P., Paschini, M., Kazak, L., Wilensky, S. E., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.04.013 · Cited by 50
PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex
Surapureddi, S., Viswakarma, N., Yu, S., Guo, D., Rao, M. S., & Reddy, J. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.160 · Cited by 49
Self-citationThe effect of regulating molecules on the structure of the PPAR-RXR complex
Amber-Vitos, O., Chaturvedi, N., Nachliel, E., Gutman, M., & Tsfadia, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.003 · Cited by 48
Petr, M., Šťastný, P., Zając, A., Tufano, J. J., & Maciejewska, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051472 · Cited by 48
Barone, R. M. E., Rizzo, R., Tabbì, G., Malaguarnera, M., Frye, R. E., & Bastin, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081878 · Cited by 44
PPARα and NCOR/SMRT corepressor network in liver metabolic regulation
Kang, Z., & Fan, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000055rr · Cited by 44
Wang, L. L., Zhang, Z. C., Hassan, W., Li, Y., Liu, J., & Shang, J. (2015) · Hepatology Research · doi:10.1111/hepr.12557 · Cited by 40
Zhou, Y., Lin, S., Zhang, L., & Li, Y. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2576-y · Cited by 40
Spitler, K. M., Ponce, J., Oudit, G. Y., Hall, D. D., & Grueter, C. E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00728.2016 · Cited by 40
Batatinha, H., de Lima, E. A., Teixeira, A. A. D. S., de Souza, C. O., Biondo, L. A., Silveira, L. S., Lira, F. S., & Neto, J. C. R. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25440 · Cited by 39
Tan, H. W. S., Anjum, B., Shen, H., Ghosh, S., Yen, P. M., & Sinha, R. A. (2019) · Autophagy · doi:10.1080/15548627.2019.1609847 · Cited by 39
Lai, Y.-H., Choudhary, K., Cloutier, S. C., Xing, Z., Aviran, S., & Tran, E. J. (2019) · Genetics · doi:10.1534/genetics.119.302058 · Cited by 39
Steroid receptor/coactivator binding inhibitors: An update
Skowron, K. J., Booker, K., Cheng, C., Creed, S. M., David, B. P., Lazzara, P. R., Lian, A., Siddiqui, Z., Speltz, T. E., & Moore, T. W. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110471 · Cited by 39
Kim, T. H., Kim, M., JO, S., Park, J.-M., & Ahn, Y. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.3.545 · Cited by 38
Surapureddi, S., Rana, R., Reddy, J. K., & Goldstein, J. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048983 · Cited by 37
Self-citationKebbaj, Z. E., Andreoletti, P., Mountassif, D., Kabine, M., Schohn, H., Dauça, M., Latruffe, N., Kebbaj, M. S. E., & Cherkaoui‐Malki, M. (2008) · Endocrinology · doi:10.1210/en.2008-1394 · Cited by 36
Self-citationAkbıyık, F., Cinar, K., Demirpençe, E., Ozsullu, T., Tunca, R., Haziroglu, R., Yurdaydın, C., Uzunalımoǧlu, Ö., & Bozkaya, H. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01359.x · Cited by 36
Cited by
Functional states of myeloid cells in cancer
van Vlerken-Ysla, L., Tyurina, Y. Y., Kagan, V. E., & Gabrilovich, D. I. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.009 · Cited by 261
Metadata
- Authors
- Tahri-Joutey, M., Andreoletti, P., Surapureddi, S., Nasser, B., Cherkaoui-Malki, M., & Latruffe, N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-08-20
- Volume
- 22
- Issue
- 16
- Pages
- 8969
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3193852162
- Cited by
- 253
- References
- 236
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.